Literature DB >> 7535358

Immunohistochemical changes in synovial tissue during the course of adjuvant arthritis.

C Pelegrí1, A Franch, C Castellote, M Castell.   

Abstract

OBJECTIVE: To study immunohistochemical changes occurring in knee synovial membranes of rats during the time course of adjuvant arthritis (AA). The effect of treatment with dexamethasone after establishment of arthritis was also studied.
METHODS: AA was induced in Wistar rats by means of a single injection of a suspension of Mycobacterium butyricum. On Days 7, 14, 17, 21, 28 and 42 after induction, synovial membranes were obtained, frozen and sectioned on a cryostat. Tissue sections were tested by peroxidase-antiperoxidase method, using the following monoclonal antibodies: OX19 (CD5), W3/25 (CD4), OX8 (CD8), OX6 (Ia), OX33 (LCA) and OX39 (CD25).
RESULTS: Knee synovial membranes obtained from arthritic rats on days of maximum inflammation showed few or no CD5+ cells, a higher proportion of CD8+ cells, and a higher number of CD4+ and Ia+ cells than healthy synovial tissues. CD25+ cells were observed from Day 7 postinduction and remained numerous throughout the study.
CONCLUSION: Few T lymphocytes (CD5+) were found in arthritic synovial membrane, whereas an increase of cells expressing CD8, CD4, CD25, Ia, and LCA was found. These increases (except CD8) are not evident in dexamethasone treated rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535358

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

2.  Alterations of lymphocyte populations in lymph nodes but not in spleen during the latency period of adjuvant arthritis.

Authors:  M Rodríguez-Palmero; C Pelegrí; M J Ferri; M Castell; A Franch; C Castellote
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

3.  Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease.

Authors:  K A Bush; J S Walker; C S Lee; B W Kirkham
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Immunohistochemical study of lymphoid tissues in adjuvant arthritis (AA) by image analysis; relationship with synovial lesions.

Authors:  M Carol; C Pelegrí; C Castellote; A Franch; M Castell
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

5.  Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate.

Authors:  M Higaki; T Ishihara; N Izumo; M Takatsu; Y Mizushima
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

6.  Boi-ogi-to (TJ-20), a Kampo Formula, Suppresses the Inflammatory Bone Destruction and the Expression of Cytokines in the Synovia of Ankle Joints of Adjuvant Arthritic Rats.

Authors:  Xinwen Zhang; Zhou Wu; Yicong Liu; Junjun Ni; Chunfu Deng; Baohong Zhao; Hiroshi Nakanishi; Jing He; Xu Yan
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-07       Impact factor: 2.629

7.  Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints.

Authors:  Nicola J Barton; David A Stevens; Jane P Hughes; Adriano G Rossi; Iain P Chessell; Alison J Reeve; Daniel S McQueen
Journal:  J Inflamm (Lond)       Date:  2007-06-13       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.